ArticleSocial cognitive and affective neuroscience2025
Social cognition in basal ganglia pathologies: Theory of Mind in Huntington's and Parkinson's diseases.
Article in Social cognitive and affective neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Neural correlates of emotional prosody in Parkinson's disease: A systematic review.Cognitive, affective & behavioral neuroscience · 2026Pooled it
- Social cognition in Parkinson's disease: a comprehensive systematic review and integrative conceptual framework.Frontiers in aging neuroscience · 2026Pooled it
- Multidimensional Phenotyping and Predictive Neuropsychological Modeling of Socio-Cognitive Endophenotypes in Early Parkinson's Disease.Brain sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Theory of Mind (ToM) is the ability to predict the behaviour of others by inferring their cognitive and affective states. The literature suggests that different neural substrates within the basal ganglia are involved in the affective (ventral striatum) and cognitive (dorsal striatum) components of ToM. We investigated ToM dysfunction in two different basal ganglia pathologies, Huntington's disease (HD) and Parkinson's disease (PD), in their early stages. Indeed, a different progression of neurodegeneration from the dorsal striatum to the ventral striatum is described in the two diseases. We also investigated whether there is a correlation between ToM and executive function. Twenty-one patients with HD, 21 with PD, and 22 healthy subjects (HS) were recruited. All participants completed a ToM assessment using the Yoni task, which assesses both cognitive and affective components at two levels of meta-representational difficulty (i.e. first-order items only require inferring the mental state of a person, while second-order items also require inferring the mental states of a person about others). The clinical groups also underwent a full neuropsychological assessment. In HD patients, both cognitive and affective ToM were equally impaired, whereas in PD patients, impairment of the cognitive component predominated. Specifically, compared to HS, HD patients scored lower on both inferential levels and on both cognitive and affective components, whereas PD patients scored lower than HS only on second-order and cognitive items. In the clinical groups, there was an imbalance between the cognitive and affective components, with higher accuracy on affective items. Performance on the Yoni task did not correlate with tests assessing executive functions. We suggest that the different pattern of ToM alteration in HD and PD may be a result of differential involvement of the ventral and dorsal striatum and that ToM abilities in these clinical populations are not directly supported by executive functioning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.